公开(公告)号：US11345883B2

公开(公告)日：2022-05-31

申请号：US16093267

申请日：2017-04-12

申请人： CHR. HANSEN A/S

发明人： Thomas Janzen ,  Sonja Bloch

IPC分类号： C12N1/20 ,  A23C9/123 ,  C12N9/10 ,  C12R1/225 ,  C12R1/245

摘要： The present invention relates to a novel Lactobacillus strain that is not attacked by common phages and a novel Lactobacillus strain with improved cell count stability, its use in the manufacture of fermented milk-based products, and novel milk based products containing the strain.

公开(公告)号：US11273188B2

公开(公告)日：2022-03-15

申请号：US15774328

申请日：2016-11-08

申请人： MICROBIOTICA GMBH

发明人： Hyeon Jin Kim ,  Seong Tshool Hong ,  Jae Gak Yu

IPC分类号： A61K35/744 ,  A61K35/747 ,  A61K35/74 ,  A23L33/10 ,  A23L33/135 ,  C12R1/225 ,  C12N1/20 ,  A61P3/04 ,  A61K9/00 ,  A61K35/00

摘要： Provided are gut microbes or cultures having anti-obesity efficacy and a pharmaceutical composition containing them. The gut microbes or cultures have anti-obesity efficacy by lowering fatty acid concentration of the gut fluid contents in a mammalian gastrointestinal tract for the prevention and treatment of obesity and obesity related diseases. This invention demonstrated that said gut microbes having anti-obesity efficacy by lowering fatty acid concentration of the gut fluid contents in the gastrointestinal tract of mammals have the anti-obesity efficacy as much as that of the representative anti-obesity drug, orlistat, without any side effects in animal experiments and clinical trials. Therefore, the gut microbes h can be used to develop universal anti-obesity drugs for obese patients, contributing greatly to the health of mankind.

公开(公告)号：US11241463B2

公开(公告)日：2022-02-08

申请号：US16848317

申请日：2020-04-14

申请人： MORINAGA MILK INDUSTRY CO., LTD.

发明人： Tomohiro Tanaka ,  Noriyuki Iwabuchi ,  Yohei Sato ,  Kanetada Shimizu ,  Toshitaka Odamaki

IPC分类号： C12N1/20 ,  A61K35/747 ,  A23L33/135 ,  A23K10/12 ,  A23K10/16 ,  A23K10/18 ,  A23L2/52 ,  A61K35/74 ,  A61K39/145 ,  C12R1/225 ,  A61K35/00 ,  A61K39/00

摘要： A composition includes cells of Lactobacillus paracasei MCC1849 (NITE BP-01633). The composition is in the form of a pharmaceutical composition, a food, a drink, or a feed. The pharmaceutical composition can be used for treating an inflammatory disease, ulcer, food allergies, bronchial asthma, urticaria, pollinosis, anaphylactic shock or an opportunistic infection.

公开(公告)号：US11160295B2

公开(公告)日：2021-11-02

申请号：US16119824

申请日：2018-08-31

申请人： Erdinger Weissbräu Werner Brombach GmbH & Co. KG

发明人： Malaika Fischer ,  Peter Liebert ,  Stefan Kreisz

IPC分类号： C12C11/06 ,  C12C11/00 ,  A23L2/38 ,  A23L2/52 ,  A23L33/135 ,  C12N1/20 ,  A23L31/15 ,  C12C12/00 ,  C12C5/02 ,  A23L33/15 ,  A23L33/14 ,  C12N1/18 ,  C12C3/00 ,  A23L33/145 ,  A23L29/00 ,  C12R1/225 ,  C12R1/865

摘要： A method for producing a food or a precursor of the same, including the steps: (a) providing a mash or a wort or last runnings as a first nutrient medium; and (b) treatment of the first nutrient medium with lactic acid bacteria of the species Lactobacillus rossiae (DSM 15814T) or with lactic acid bacteria of at least two kinds of species including Lactobacillus rossiae (DSM 15814T). Furthermore, a corresponding food and corresponding uses are claimed.

公开(公告)号：US11130938B2

公开(公告)日：2021-09-28

申请号：US16544504

申请日：2019-08-19

申请人： Probiotical S.p.A. ,  Vera Mogna

发明人： Giovanni Mogna ,  Gian Paolo Strozzi

IPC分类号： C12N1/20 ,  A23L33/135 ,  C12R1/225 ,  C12R1/01 ,  C12R1/23 ,  C12R1/25 ,  C12R1/44 ,  C12R1/46 ,  C12R1/245

摘要： The present invention provides anallergic compositions, including food products, comprising probiotic bacterial cultures including probiotic strains of Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus, and/or Staphylococcus.

公开(公告)号：US11077154B2

公开(公告)日：2021-08-03

申请号：US16099987

申请日：2017-05-09

申请人： Deerland Probiotics & Enzymes A/S

发明人： Erik Brandsborg

IPC分类号： A61K35/747 ,  C12N1/20 ,  C12R1/225 ,  A61P1/02

摘要： The present invention relates to a Lactobacillus curvatus strain. In particular, the present invention relates to a composition comprising a Lactobacillus curvatus strain in combination with a further Lactobacillus and the use of the same in the treatment of inflammatory conditions in the oral cavity.

公开(公告)号：US20210230535A1

公开(公告)日：2021-07-29

申请号：US17012797

申请日：2020-09-04

申请人： Chio Kang Medical, Inc. ,  QIAOKANG BIOTECH (GUANGDONG) CO., LTD.

发明人： Dongxin Hou ,  Jianlong Xue ,  Jiali Lin ,  Xin Yin ,  Yecheng He ,  Shengwei Hu ,  Qinghua Xiao ,  Liqing Zhu ,  Lixiong Feng

IPC分类号： C12N1/36 ,  C12N1/20 ,  C12R1/125 ,  C12R1/02 ,  C12R1/225 ,  A62D3/02 ,  C02F3/34 ,  B01D53/84 ,  B01D53/72

摘要： The present disclosure relates to strains for degrading ethylene oxide and degradation agents comprising the same, wherein the strains are Acetobacter peroxydans EO-01 strain with Deposit number of CGMCC No. 18431; Lactobacillus fermentum EO-02 strain with Deposit number of CGMCC No. 18432; or Bacillus subtilis EO-03 strain with Deposit number of CGMCC No. 18433. The strains are capable of safely and efficiently degrading ethylene oxide. The present disclosure also provides a method for purifying and producing strains that can degrade ethylene oxide, and a method for biodegrading ethylene oxide.

公开(公告)号：US10993974B2

公开(公告)日：2021-05-04

申请号：US16292246

申请日：2019-03-04

申请人： CHR. HANSEN A/S

发明人： Tina Hornbaek ,  Maike Lisberg ,  Silja Kej Diemer

IPC分类号： A61K35/747 ,  A01N63/00 ,  A23C9/123 ,  C12R1/225

摘要： The present invention is related to the field of bioprotection, in particular to an antimicrobial composition comprising a Lactobacillus rhamnosus strain and/or a Lactobacillus paracasei strain. Furthermore, the present invention concerns uses for such an antimicrobial composition, food, feed and pharmaceutical products comprising such an antimicrobial composition, a method of manufacturing such food, feed and pharmaceutical products and a method for reducing the content of unwanted microorganisms of such food, feed and pharmaceutical products.

公开(公告)号：US10927340B2

公开(公告)日：2021-02-23

申请号：US14116996

申请日：2012-05-09

申请人： Giovanni Mogna ,  Gian Paolo Strozzi ,  Luca Mogna

发明人： Giovanni Mogna ,  Gian Paolo Strozzi ,  Luca Mogna

IPC分类号： C12N1/20 ,  C12R1/225 ,  A61K35/747 ,  A61K31/733 ,  A61K31/702

摘要： A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.

公开(公告)号：US20210040513A1

公开(公告)日：2021-02-11

申请号：US17073977

申请日：2020-10-19

申请人： S&P Ingredient Development, LLC

发明人： Paul Blum ,  Sambasiva Rao Chigurupati ,  Derrick Jermaine White

IPC分类号： C12P7/52 ,  C12R1/145 ,  C12R1/02 ,  C12R1/225

摘要： Microbial cell lines suitable for industrial-scale production of organic acids and methods of making and isolating such cell lines.